share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰製藥 | 4：持股變動聲明-高管 Bozic Carmen
美股sec公告 ·  06/01 04:33
牛牛AI助理已提取核心訊息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on May 29, 2024. The transaction was executed at a price of $445.56 per share, resulting in a total sale value of approximately $1,015,876.80. Following the sale, Bozic's direct holdings in the company amount to 34,659 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on May 29, 2024. The transaction was executed at a price of $445.56 per share, resulting in a total sale value of approximately $1,015,876.80. Following the sale, Bozic's direct holdings in the company amount to 34,659 shares. The sale took place through an open market transaction, as reported in the company's latest filing.
Vertex Pharmicals Inc.（VRTX）執行副總裁兼首席營銷官卡門·博齊奇於2024年5月29日完成了2,280股普通股的出售。該交易以每股445.56美元的價格執行，總銷售價值約爲1,015,876.80美元。出售後，Bozic在該公司的直接持股量爲34,659股。據該公司最新文件所述，此次出售是通過公開市場交易進行的。
Vertex Pharmicals Inc.（VRTX）執行副總裁兼首席營銷官卡門·博齊奇於2024年5月29日完成了2,280股普通股的出售。該交易以每股445.56美元的價格執行，總銷售價值約爲1,015,876.80美元。出售後，Bozic在該公司的直接持股量爲34,659股。據該公司最新文件所述，此次出售是通過公開市場交易進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。